20Med Therapeutics

📍 Enschede, Netherlands🗓 Founded 2011👥 17 employees💰 Last funded Sep 2021
Biotechnology Research🌐 20medtx.com
Website LinkedIn
20Med Therapeutics is a biomedical company developing innovative solutions for efficient intracellular delivery of RNA and DNA based vacccines and therapeutics. 20Meds proprietary highly innovative nanoparticles are designed with several smart functions that make them efficient in protecting fragile payload, transport, cellular uptake, and release of active Oligonucleotide based payloads into the cytoplasm of target cells. 20Meds nanoparticles are flexible in functionalization and their unique properties make them applicable in a broad field of medical therapeutics.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in 20Med Therapeutics?
20Med Therapeutics has 1 investors on record on gritt.io and 1 late-stage investors.
When did 20Med Therapeutics last raise funding?
The most recent investment in 20Med Therapeutics recorded on gritt.io was in September 2021.
When was 20Med Therapeutics founded?
20Med Therapeutics was founded in 2011.
What industry is 20Med Therapeutics in?
20Med Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is 20Med Therapeutics based?
20Med Therapeutics is headquartered in Enschede, Netherlands.